BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38733417)

  • 21. 2023 FIGO staging system for endometrial cancer: The evolution of the revolution.
    Gaffney D; Matias-Guiu X; Mutch D; Scambia G; Creutzberg C; Fotopoulou C; Berek JS; Concin N
    Gynecol Oncol; 2024 May; 184():245-253. PubMed ID: 38447389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience.
    Chen KS; Berhane H; Gill BS; Olawaiye A; Sukumvanich P; Kelley JL; Boisen MM; Courtney-Brooks M; Comerci JT; Edwards R; Berger J; Beriwal S
    Gynecol Oncol; 2017 Nov; 147(2):315-319. PubMed ID: 28866431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of pretreatment leukocytosis and thrombocytosis into the FIGO staging system for prognosis in surgically treated endometrial cancer.
    Yokoi E; Mabuchi S; Komura N; Shimura K; Matsumoto Y; Kimura T
    Int J Gynaecol Obstet; 2020 Nov; 151(2):272-278. PubMed ID: 32712993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A suggested modification to FIGO stage I endometrial cancer.
    Aristizabal P; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
    Gynecol Oncol; 2014 May; 133(2):192-6. PubMed ID: 24631453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the 2021 FIGO staging schema for advanced vulvar cancer.
    Matsuo K; Klar M; Nishio S; Mikami M; Roman LD; Wright JD
    Int J Gynecol Cancer; 2022 Apr; 32(4):474-479. PubMed ID: 34996835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 31. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
    Page BR; Pappas L; Cooke EW; Gaffney DK
    Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy.
    Cahan B; Kim JH; Schultheiss TE; Wong JYC; Chen YJ
    Am J Clin Oncol; 2018 Mar; 41(3):302-306. PubMed ID: 26886945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
    Ballester M; Koskas M; Coutant C; Chéreau E; Seror J; Rouzier R; Daraï E
    BMC Cancer; 2010 Aug; 10():465. PubMed ID: 20804553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
    Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
    Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Tang X; Guo C; Liu S; Guo J; Hua K; Qiu J
    Int J Gynaecol Obstet; 2021 Oct; 155(1):86-94. PubMed ID: 33587753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.